Suministro de medicamentos antineoplásicos, anticuerpos monoclonales (Subgrupo terapéutico L01XC)
Published
Value
Description
Suministro de medicamentos antineoplásicos, anticuerpos monoclonales (Subgrupo terapéutico L01XC) Lot 1: Cetuximab 5mg/ml Vial Cetuximab 5mg/ml Vial Lot 10: Trastuzumab Emtansina 160 mg Vial Trastuzumab Emtansina 160 mg Vial Lot 11: Obinutuzumab 1000 mg Vial Obinutuzumab 1000 mg Vial Lot 12: Nivolumab 10 mg/ml Vial Nivolumab 10 mg/ml Vial Lot 13: Pembrolizumab 25 mg/ml Vial Pembrolizumab 25 mg/ml Vial Lot 14: Ramucirumab 10mg/ml Vial Ramucirumab 10mg/ml Vial Lot 15: Daratumumab 20mg /ml Vial Daratumumab 20mg /ml Vial Lot 16: Daratumumab 1800 mg Vial Daratumumab 1800 mg Vial Lot 17: Inotuzumab Ozogamicina 1 mg Vial Inotuzumab Ozogamicina 1 mg Vial Lot 18: Durvalumab Imfinzi 50 mg/ml Vial Durvalumab Imfinzi 50 mg/ml Vial Lot 19: Avelumab 20 mg/ml Vial Avelumab 20 mg/ml Vial Lot 2: Rituximab 1400 mg Vial Rituximab 1400 mg Vial Lot 20: Atezolizumab 1200 mg Vial Atezolizumab 1200 mg Vial Lot 3: Trastuzumab 600 Mg Vial Trastuzumab 600 Mg Vial Lot 4: Gemtuzumab Ozogamicina 5mg Vial Gemtuzumab Ozogamicina 5mg Vial Lot 5: Panitumumab 20mg/ml Vial Panitumumab 20mg/ml Vial Lot 6: Ipilimumab 5mg/ml Vial Ipilimumab 5mg/ml Vial Lot 7: Brentuximab 50 mg Vial Brentuximab 50 mg Vial Lot 8: Pertuzumab 420 mg Vial Pertuzumab 420 mg Vial Lot 9: Trastuzumab Emtansina 100 mg Vial Trastuzumab Emtansina 100 mg Vial Lot 1: Cetuximab 5mg/ml Vial Cetuximab 5mg/ml Vial Lot 10: Trastuzumab Emtansina 160 mg Vial Trastuzumab Emtansina 160 mg Vial Lot 11: Obinutuzumab 1000 mg Vial Obinutuzumab 1000 mg Vial Lot 12: Nivolumab 10 mg/ml Vial Nivolumab 10 mg/ml Vial Lot 13: Pembrolizumab 25 mg/ml Vial Pembrolizumab 25 mg/ml Vial Lot 14: Ramucirumab 10mg/ml Vial Ramucirumab 10mg/ml Vial Lot 15: Daratumumab 20mg /ml Vial Daratumumab 20mg /ml Vial Lot 16: Daratumumab 1800 mg Vial Daratumumab 1800 mg Vial Lot 17: Inotuzumab Ozogamicina 1 mg Vial Inotuzumab Ozogamicina 1 mg Vial Lot 18: Durvalumab Imfinzi 50 mg/ml Vial Durvalumab Imfinzi 50 mg/ml Vial Lot 19: Avelumab 20 mg/ml Vial Avelumab 20 mg/ml Vial Lot 2: Rituximab 1400 mg Vial Rituximab 1400 mg Vial Lot 20: Atezolizumab 1200 mg Vial Atezolizumab 1200 mg Vial Lot 3: Trastuzumab 600 Mg Vial Trastuzumab 600 Mg Vial Lot 4: Gemtuzumab Ozogamicina 5mg Vial Gemtuzumab Ozogamicina 5mg Vial Lot 5: Panitumumab 20mg/ml Vial Panitumumab 20mg/ml Vial Lot 6: Ipilimumab 5mg/ml Vial Ipilimumab 5mg/ml Vial Lot 7: Brentuximab 50 mg Vial Brentuximab 50 mg Vial Lot 8: Pertuzumab 420 mg Vial Pertuzumab 420 mg Vial Lot 9: Trastuzumab Emtansina 100 mg Vial Trastuzumab Emtansina 100 mg Vial
Timeline
Close date
3 years ago
Publish date
3 years ago
Buyer information
Subsecretaría de la Consellería de Sanidad y Salud Pública
- Contact:
- Subsecretaría de la Consellería de Sanidad y Salud Pública
- Email:
- sac_san@gva.es
Explore contracts and tenders relating to Subsecretaría de la Consellería de Sanidad y Salud Pública
Go to buyer profileNotice topic
Source
Ted (OJEU)To save this opportunity, sign up to Stotles for free.
Save in appTender tracking
Access a feed of government opportunities tailored to you, in one view. Receive email alerts and integrate with your CRM to stay up-to-date.
Proactive prospecting
Get ahead of competitors by reaching out to key decision-makers within buying organisations directly.
360° account briefings
Create in-depth briefings on buyer organisations based on their historical & upcoming procurement activity.
Collaboration tools
Streamline sales workflows with team collaboration and communication features, and integrate with your favourite sales tools.
Explore similar tenders and contracts
Browse open tenders, recent contract awards and upcoming contract expiries that match similar CPV codes.
- Closed
MEDICAMENTOS ONCOLÓGICOS (I)
Consorcio Corporació Sanitària Parc Taulí de Sabadell21,976,730 EURPublished a year ago
- Closed
Léčivé přípravky s obsahem daratumumabu
Consejería de Inclusión Social, Juventud, Familias e Igualdad455,000 EURPublished a year ago
- Closed
Léčivé přípravky s obsahem erlotinibu
Alcaldía del Ayuntamiento de Castelló7,382,500 CZKPublished a year ago
- Closed
PA HUPA 63/23 medicamentos genéricos
Hospital Universitario Príncipe de Asturias1,610,112 EURPublished a year ago
- Closed
FN Motol - Selperkatinib
Junta de Gobierno Local del Ayuntamiento de Alicante813,223 EURPublished 2 years ago
- Openclosing
Adquisición de la especialidad farmacéutica VERZENIOS 100, 150 Y 50MG COMP. C/56 (ABEMACICLIB), con destino al Servicio de Farmacia del Hospital Universitario Ramón y Cajal
Hospital Universitario Ramón y Cajal5,120,970 EURPublished 2 years ago
- Closed
FN Motol - Dasatinib
Subsecretaría del Ministerio de la Presidencia, Relaciones con las Cortes y Memoria Democrática4,563,526 HRKPublished 2 years ago
- Closed
Suministro de medicamentos antineoplásicos, anticuerpos monoclonales (Subgrupo terapéutico L01XC)
Subsecretaría de la Consellería de Sanidad y Salud Pública420,448,674 EURPublished 3 years ago
- Closed
FN Motol - Bevacizumab
Instituto Municipal de Mercados de Barcelona81,564,599 CZKPublished 3 years ago
Explore more suppliers to Subsecretaría de la Consellería de Sanidad y Salud Pública
Sign upExplore top buyers for public sector contracts
Discover open tenders, contract awards and upcoming contract expiries of thousands of public sector buyers below. Gain insights into their procurement activity, historical purchasing trends and more.
- Northamptonshire County Council
- Velindre University NHS Trust
- Staffordshire Police and Staffordshire Fire & Rescue Service
- Kingdom Housing Association Ltd
- States of Jersey
- Energy Systems Catapult
- Department of Health
- Amey Rail Limited
- Housing Finance Agency Plc
- Office of the Comptroller and Auditor General
- Shrewsbury Colleges Group
- Balgowan Primary School
Explore top sources for public sector contracts
Stotles aggregates public sector contract data from every major procurement data source. We ingest this data and surface the most relevant insights for our users. Explore our list of public sector procurement data sources below.